A phase III study of topical alprostadil cream (Femprox) for female sexual arousal disorder.

Trial Profile

A phase III study of topical alprostadil cream (Femprox) for female sexual arousal disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2012

At a glance

  • Drugs Alprostadil (Primary)
  • Indications Female sexual dysfunction
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2008 Primary endpoint 'Sexual-satisfaction' has been met.
    • 01 Aug 2008 Results have been published in The Journal of Sexual Medicine.
    • 20 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top